Mint Tower Capital Management B.V. »

Phoenix Biotech Acquisition Class A shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.5M 141k 10.86
2023-06-30 $1.5M 141k 10.90
2023-03-31 $1.5M 141k 10.68
2022-12-31 $1.4M 141k 10.27
2022-09-30 $807k 80k 10.09

More positions owned by Mint Tower Capital Management B.V.

On Semiconductor Corp Note 1.625%10/1 (Principal)
Carnival Corp Note 5.750%10/0 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Palo Alto Networks Note 0.375% 6/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Etsy Note 0.125%10/0 (Principal)
iShares MSCI Brazil Index Call Option (EWZ)
Activision Blizzard
Apple Call Option (AAPL)
Devon Energy Corporation Call Option (DVN)
Financial Select Sector SPDR Put Option (XLF)
Morgan Stanley Put Option (MS)
Exxon Mobil Corporation Put Option (XOM)
United States Stl Corp Note 5.000%11/0 (Principal)
Chipotle Mexican Grill Call Option (CMG)

View all positions for Mint Tower Capital Management B.V.

Top funds holding Phoenix Biotech Acquisition Class A

Cantor Fitzgerald, L. P.
Walleye Trading Advisors
Berkley W R
Walleye Trading
FNY Investment Advisers
Kestra Private Wealth Services
PenderFund Capital Management

View all funds holding Phoenix Biotech Acquisition Class A